Abstract | OBJECTIVE: To correlate parameters of endometriosis obtained during routine clinical evaluation with the subsequent formation of adhesions following surgical treatment by laparoscopy. DESIGN: Randomized, controlled, double-blind, clinical trial. SETTING: PATIENT(S): INTERVENTION: Laparoscopic surgical treatment of endometriosis, followed by randomization to Oxiplex/AP (FzioMed, Inc., San Luis Obispo, California) gel treatment (treated group) of adnexa, or surgery alone (control group); follow-up laparoscopy 6-10 weeks later. MAIN OUTCOME MEASURE(S): Adnexal Americn Fertility Society score, correlated with color and location of endometriosis, as well as stage of disease determined by masked review of videotapes. RESULT(S): Control patients with at least 50% red lesions had a greater increase in ipsilateral adnexal adhesion scores than patients with mostly black or white and/or clear lesions. Treated patients with red lesions had a greater decrease in adnexal adhesion scores than control patients. There was a correlation between baseline endometriosis stage and postoperative adhesion formation in control patients, but not treated patients. CONCLUSION(S): Patients with red endometriotic lesions had greater increases in their adhesion scores than patients with only black, white, and/or clear lesions. Oxiplex/AP gel was effective in reducing adhesions, compared to surgery alone, in all groups.
|
Authors | Gere S diZerega, James Coad, Jacques Donnez |
Journal | Fertility and sterility
(Fertil Steril)
Vol. 87
Issue 3
Pg. 485-9
(Mar 2007)
ISSN: 1556-5653 [Electronic] United States |
PMID | 17126335
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Gels
- Oxiplex
- Polyethylene Glycols
- Cellulose
|
Topics |
- Cellulose
(analogs & derivatives, therapeutic use)
- Color
- Double-Blind Method
- Endometriosis
(surgery)
- Female
- Gels
(therapeutic use)
- Gynecologic Surgical Procedures
(adverse effects)
- Humans
- Laparoscopy
(adverse effects)
- Polyethylene Glycols
(therapeutic use)
- Tissue Adhesions
(prevention & control)
|